ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

ADILW Adial Pharmaceuticals Inc

0,0009
0,00 (0,00%)
Avant marché
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Adial Pharmaceuticals Inc ADILW NASDAQ Warrant
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 0,0009 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,0009
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/6/202414:30GLOBEAdial Pharmaceuticals Achieves Important Milestone of First..
29/5/202414:30GLOBEAdial CEO to Present at the Spring MicroCap Rodeo Conference..
15/5/202414:30GLOBEAdial Pharmaceuticals Reports First Quarter 2024 Financial..
22/4/202414:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/4/202414:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/4/202414:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
02/3/202401:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
28/2/202415:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
13/2/202415:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
18/1/202414:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
20/12/202315:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
29/11/202322:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
14/11/202323:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
31/10/202313:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
25/10/202314:00GLOBEAddiction Experts Highlight the Need for..
24/10/202322:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
20/10/202314:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
19/10/202316:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
18/10/202314:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
28/9/202313:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
05/9/202314:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
28/8/202314:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
23/8/202314:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
21/8/202314:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
04/8/202314:30GLOBEAdial Pharmaceuticals Announces Reverse Stock Split to..
11/7/202314:30GLOBEAdial Provides Business Update Following Favorable Comments..

Dernières Valeurs Consultées